glp-1 and eyesight drugs may be linked to higher risk of eye disease: study FDA just approved first Number of Vials:3 Vials (Differentiated Results) Daniel Fast

glp-1 and eyesight drugs may be linked to higher risk of eye disease: study FDA just approved first Number of Vials:3 Vials (Differentiated Results) Daniel Fast

FDA just approved first generic GLP-1 for #WeightLoss: Liraglutide (Saxenda). | Chris Aiken, MD

Recent research from Penn Medicine suggests the effect may be temporary, but their case study only involved one person

Daniel Fast

Number of Vials:3 Vials (Differentiated Results)

Here's what typically makes someone eligible: BMI Requirements Primary eligibility usually requires: BMI of 30 or higher (classified as obesity), OR BMI of 27 or higher with at least one weight-related health condition Your BMI is calculated using your height and weight, but it's important to remember that BMI doesn't tell the whole story about your health